Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aris Persidis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Assay and Drug Development Technologies|August 5, 2015
Drug Repositioning and Off-Label Use-Finding the Balance and Understanding the Differences: Interview with David Cavalla, MA, PhD, Founder, NumedicusDavid Cavalla, Aris Persidis
Pharmacogenomics|October 8, 2004
Systems literature analysisAndreas Persidis, Spyros Deftereos, Aris Persidis
Expert Review of Clinical Pharmacology|September 5, 2012
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitorsSpyros N Deftereos, Evie Dodou, Christos Andronis, et al.
Briefings in Bioinformatics|June 30, 2011
Literature mining, ontologies and information visualization for drug repurposingChristos Andronis, Anuj Sharma, Vassilis Virvilis, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 19, 2011
Drug repurposing and adverse event prediction using high-throughput literature analysisSpyros N Deftereos, Christos Andronis, Ellen J Friedla, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Assay and Drug Development Technologies|August 5, 2015
Drug Repositioning and Off-Label Use-Finding the Balance and Understanding the Differences: Interview with David Cavalla, MA, PhD, Founder, NumedicusDavid Cavalla, Aris Persidis
Pharmacogenomics|October 8, 2004
Systems literature analysisAndreas Persidis, Spyros Deftereos, Aris Persidis
Expert Review of Clinical Pharmacology|September 5, 2012
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitorsSpyros N Deftereos, Evie Dodou, Christos Andronis, et al.
Briefings in Bioinformatics|June 30, 2011
Literature mining, ontologies and information visualization for drug repurposingChristos Andronis, Anuj Sharma, Vassilis Virvilis, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 19, 2011
Drug repurposing and adverse event prediction using high-throughput literature analysisSpyros N Deftereos, Christos Andronis, Ellen J Friedla, et al.
Pageof 1